NPM1 is the most commonly mutated gene in adult AML, occurring in approximately 30% of all cases, and it is considered to be a prognostic factor of favorable risk [15,34,35,36,37,38,39,40]. This evidence concerns the gene NPM1 and acute myeloid leukemia.